Heat Biologics, Inc. HTBX

Heat Biologics soars 14% on completion of ZVX-60 vaccine cell line for COVID-19
Dec. 16, 2020 7:40 AMHeat Biologics, Inc. (HTBX)By: Mamta Mayani, SA News Editor
Heat Biologics (NASDAQ:HTBX) rises 14% premarket after completing its gp96-based COVID-19 vaccine cell line ("ZVX-60"), being developed for use as either a standalone, or in combination with other vaccines to enhance prophylactic protection.

Data, generated at the University of Miami Miller School of Medicine, has confirmed expression of gp96, OX40L and Spike protein.

Also, preparations for manufacturing the vaccine are well underway.

$HTBX. This is what happens when people don’t do just the basic of research before they buy a stock.. if you know what you own, you will NOT panic sell. $30 early next YEAR!

$HTBX Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19

Wed, December 16, 2020, 7:30 AM EST
Preparations for manufacturing underway

DURHAM, NC / ACCESSWIRE / December 16, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announces it has completed its gp96-based COVID-19 vaccine cell line ("ZVX-60"), which is being developed for use as either a standalone vaccine, or in combination with other vaccines to enhance prophylactic protection. Data,

$HTBX $30 Plus by end of January.

$HTBX..THERE vaccine is already going into production. They have to already know they are going to get FDA approval to start manufacturing already. ?????

Even 7$ =$1 before split. Still lots of room to grow

Utter disaster!

What a disaster. Never again!

Take your money to $SNDL this thing is about to ????? $2-$3 eow merger/acquisition within the next few days after the price for manipulated back to .50 after reaching .98 ????

Nice assessment Kevin